Natural Sciences Active Updated Aug 1, 2026

A molecular brace targets the toxic clumps behind Parkinson's

Alpha-synuclein, a protein long considered undruggable because it lacks the pocket-shaped binding sites conventional drugs need, is one of the primary drivers of neuron damage in Parkinson's disease. Researchers built a synthetic molecule called SK-129 that binds several parts of the protein at once and holds it in a shape resistant to clumping, and the stakes are whether this approach can move from mice toward a treatment that touches the underlying disease rather than just its symptoms.